View CfT Workspace
CfT: CT2073/2022 - Supply of Diphtheria, Tetanus, Pertussis (Acellular Component), Poliomyelitis (Inactivated), Hepatitis B(RDNA) and Haemophilus Influenzae B Conjugate Vaccine (Adsorbed)
- Name of Contracting Authority:
- Department of Contracts
- Title:
- CT2073/2022 - Supply of Diphtheria, Tetanus, Pertussis (Acellular Component), Poliomyelitis (Inactivated), Hepatitis B(RDNA) and Haemophilus Influenzae B Conjugate Vaccine (Adsorbed)
- CfT CA Unique ID:
- CT2073/2022
- Evaluation Mechanism:
- Price/Cost Effectiveness
- Description:
- CT2073/2022 - Supply of Diphtheria, Tetanus, Pertussis (Acellular Component), Poliomyelitis (Inactivated), Hepatitis B (RDNA) and Haemophilus Influenzae B Conjugate Vaccine (Adsorbed)
- Procurement Type:
- Supplies
- Directive:
- 2014/24/EU (Classic)
- Procedure:
- Open
- CfT Involves:
- A Public Contract
- CPV Codes:
-
33690000-Various medicinal products
- Inclusion of e-Auctions:
- No
- NUTS codes:
- MT00
- Above or Below EU Threshold:
- Above
- Time-limit for receipt of tenders or requests to participate:
- 06/09/2022 09:30
- Deadline for dispatching invitations:
- End of clarification period:
- 16/08/2022 09:30
- Tenders Opening Date:
- 06/09/2022 10:00
- Contract awarded in Lots:
- No
- EU funding:
- No
- Multiple tenders will be accepted:
- Yes
- Contract Notice Date:
- 23/07/2022 10:58
- Award Notice Date:
- 26/01/2023 08:09
| Economic Operator | CPV Code | Lots | Contract Value (EUR) |
|---|---|---|---|
| Cherubino Ltd. | N/A | EUR1,900,260.00 |
| Economic Operator | Winner | Lots | Submitted Financial Value |
|---|---|---|---|
| Alfred Gera and Sons Ltd | No | N/A | EUR2,054,790.00 |
| Cherubino Ltd. | Yes | N/A | EUR1,900,260.00 |
All SC CfTs
| Sc ID | Title | Name of Contracting Authority | Status |
|---|